Full text loading...
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Technical note: Check software for use with trans-rectal ultrasound guided I-125 seed prostate implants
1.H. H. Holm, “The history of interstitial brachytherapy of prostatic cancer,” Semin. Surg. Oncol. 13, 431–437 (1997).
2.P. D. Grimm, J. C. Blasko, and H. Ragde, “Ultrasound-guided transperineal implantation of Iodine-125 and Palladium-103 for the treatment of early-stage prostate cancer,” Atlas Urol. Clin. N. Am. 2(2), 113–125 (1994).
3.B. Fraass et al., “American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning,” Med. Phys. 25, 1773–1829 (1998).
4.R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, “Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43,” Med. Phys. 22, 209–234 (1995).
5.S. Nag, W. Bice, K. DeWyngaert, B. Prestidge, R. Stock, and Y. Yu, “The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis,” Int. J. Radiat. Oncol., Biol., Phys. 46(1), 221–230 (2000).
Article metrics loading...